For example, in a Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI 2D) trial male patients treated with insulin sensitizers had lower episodes of DSPN over 4 years compared to those who received sulfonylurea/insulin (133). Here, INS is linked to type 2 diabetes mellitus.